Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the development and delivery of immune-based therapies for patients around the world. Zenas is rapidly advancing a deep portfolio of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune and rare diseases. For more information about Zenas BioPharma, please visit www.zenasbio.com.
Location: United States, Massachusetts, Waltham
Employees: 11-50
Total raised: $118M
Investors 2
| Date | Name | Website |
| 21.11.2022 | Vivo Capit... | vivocapita... |
| 17.11.2022 | Longitude ... | longitudec... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.11.2022 | Series B | $118M | Enavate Sc... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 05.09.2023 | Zenas BioPharma Announces Strategic License and Collaboratio... | - | vivocapita... |
| 11.11.2022 | Autoimmune Biotech Zenas Gets $118M to Take Antibody Drug In... | Zenas BioPharma is preparing to take its lead drug candidate into a global Phase 3 test and it now h... | medcitynew... |
| 10.11.2022 | Zenas BioPharma raises $118m Series B round to advance pipel... | US-based Zenas BioPharma, an immune therapy developer with operations in China, has secured $118 mil... | dealstreet... |
| 08.11.2022 | Zenas BioPharma Raises $118M in Series B Funding | Zenas BioPharma, a Waltham, MA-based biopharmaceutical company, raised $118M in Series B funding. T... | finsmes.co... |
| - | Zenas BioPharma | “Bringing innovation to patients around the world - Zenas BioPharma” | fastfounde... |